ClinicalTrials.Veeva

Menu

Dexamethasone for Pain After Shoulder Surgery

University of Aarhus logo

University of Aarhus

Status and phase

Completed
Phase 4

Conditions

Arthritis
Shoulder Impingement Syndrome

Treatments

Drug: Dexamethasone

Study type

Interventional

Funder types

Other

Identifiers

NCT01414569
2011-003082-15 (EudraCT Number)
KTB-002

Details and patient eligibility

About

The purpose of this study is to determine if a dose of 40 mg dexamethasone is more effective as pain treatment than the currently used dose of 8 mg after arthroscopic shoulder surgery.

Enrollment

97 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Arthroscopic subacromial decompression and/or acromioclavicular resection
  • General anaesthesia
  • Daysurgery, Horsens Hospital

Exclusion criteria

  • Incompetent
  • Pregnant
  • Age under 18 or over 90 years
  • Allergy toward dexamethasone
  • Diabetes
  • Active gastric ulcer
  • Untreated hypertension
  • Glaucoma
  • Daily use of glucocorticoids or strong opioids
  • Daily use of analgesics for unrelated illness
  • Myasthenia gravis
  • Mitochondrial disorders

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

97 participants in 3 patient groups, including a placebo group

8 mg dexamethasone
Active Comparator group
Treatment:
Drug: Dexamethasone
Placebo, saline
Placebo Comparator group
Treatment:
Drug: Dexamethasone
40 mg dexamethasone
Experimental group
Treatment:
Drug: Dexamethasone

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems